المؤلفون: Sveen, A, Bruun, J, Eide, PW, Eilertsen, IA, Ramirez, L, Murumagi, A, Arjama, M, Danielsen, SA, Kryeziu, K, Elez, E, Tabernero, J, Guinney, J, Palmer, HG, Nesbakken, A, Kallioniemi, O, Dienstmann, R, Lothe, RA

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 24(4):794-806

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:137642683

المؤلفون: Kolberg, M, Bruun, J, Murumagi, A, Mpindi, JP, Bergsland, CH, Holand, M, Eilertsen, IA, Danielsen, SA, Kallioniemi, O, Lothe, RA

المصدر: Molecular oncology. 11(9):1156-1171

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:136540075

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Brunsell TH; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Sveen A; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Bjørnbeth BA; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway., Røsok BI; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway., Danielsen SA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway., Brudvik KW; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway., Berg KCG; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Johannessen B; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Cengija V; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Department of Radiology and Nuclear Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Abildgaard A; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Department of Radiology and Nuclear Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Guren MG; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital Ullevål, Oslo, Norway., Nesbakken A; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway., Lothe RA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: Ragnhild.A.Lothe@rr-research.no.

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2020 Mar; Vol. 19 (1), pp. e26-e47. Date of Electronic Publication: 2019 Dec 12.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Hepatectomy*, Biomarkers, Tumor/*genetics , Colorectal Neoplasms/*pathology , Liver Neoplasms/*genetics , Neoplasm Recurrence, Local/*epidemiology, Adult ; Aged ; Aged, 80 and over ; Class I Phosphatidylinositol 3-Kinases/genetics ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/surgery ; DNA Mutational Analysis ; Disease-Free Survival ; Female ; Genetic Heterogeneity ; High-Throughput Nucleotide Sequencing ; Humans ; Kaplan-Meier Estimate ; Liver/pathology ; Liver/surgery ; Liver Neoplasms/mortality ; Liver Neoplasms/surgery ; Male ; Middle Aged ; Mutation ; Neoplasm Recurrence, Local/genetics ; Norway/epidemiology ; Prognosis ; Prospective Studies ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Young Adult

المؤلفون: Burocziova M; Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Burdova K; Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Martinikova AS; Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Kasparek P; Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Kleiblova P; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Danielsen SA; Department Molecular Oncology, Institute for Cancer Research, & K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway., Borecka M; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Jenikova G; Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Janečková L; Cell and Developmental Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Pavel J; Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Zemankova P; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Schneiderova M; Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General Faculty Hospital in Prague, Prague, Czech Republic., Schwarzova L; Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General Faculty Hospital in Prague, Prague, Czech Republic., Ticha I; Department of Oncology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.; Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Sun XF; Department of Oncology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden., Jiraskova K; Molecular Biology of Cancer, Institute of Experimental Medicine, ASCR, Prague, Czech Republic., Liska V; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic., Vodickova L; Molecular Biology of Cancer, Institute of Experimental Medicine, ASCR, Prague, Czech Republic.; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.; Institute of Biology and Medical Genetics, First Medical Faculty, Charles University, Prague, Czech Republic., Vodicka P; Molecular Biology of Cancer, Institute of Experimental Medicine, ASCR, Prague, Czech Republic.; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.; Institute of Biology and Medical Genetics, First Medical Faculty, Charles University, Prague, Czech Republic., Sedlacek R; Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Kleibl Z; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Lothe RA; Department Molecular Oncology, Institute for Cancer Research, & K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway., Korinek V; Cell and Developmental Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Macurek L; Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic. libor.macurek@img.cas.cz.

المصدر: Cell death & disease [Cell Death Dis] 2019 Oct 28; Vol. 10 (11), pp. 818. Date of Electronic Publication: 2019 Oct 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

مواضيع طبية MeSH: Adenomatous Polyposis Coli Protein/*genetics , Colonic Neoplasms/*drug therapy , Protein Phosphatase 2C/*genetics , Tumor Suppressor Protein p53/*genetics, Animals ; Carcinogenesis/drug effects ; Cell Cycle Checkpoints/genetics ; Cell Proliferation/drug effects ; Chromatin/drug effects ; Colonic Neoplasms/genetics ; Colonic Neoplasms/pathology ; DNA Damage/drug effects ; DNA Repair/drug effects ; Exons/genetics ; Fluorouracil/pharmacology ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Mice ; Mutation/genetics

المؤلفون: Berg KCG; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, P.O. Box 4950, Nydalen, NO-0424, Oslo, Norway., Sveen A; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, P.O. Box 4950, Nydalen, NO-0424, Oslo, Norway., Høland M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, P.O. Box 4950, Nydalen, NO-0424, Oslo, Norway., Alagaratnam S; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway., Berg M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; Gastrointestinal Translational Research Unit, Lab for Molecular Biology, Stavanger University Hospital, P.O. Box 8100, NO-4011, Stavanger, Norway., Danielsen SA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway., Nesbakken A; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, P.O. Box 4950, Nydalen, NO-0424, Oslo, Norway.; Department of Gastrointestinal Surgery, Oslo University Hospital, P.O. Box 4950, Nydalen, NO-0424, Oslo, Norway., Søreide K; Gastrointestinal Translational Research Unit, Lab for Molecular Biology, Stavanger University Hospital, P.O. Box 8100, NO-4011, Stavanger, Norway.; Department of Gastrointestinal Surgery, Stavanger University Hospital, P.O. Box 8100, NO-4011, Stavanger, Norway.; Department of Clinical Medicine, University of Bergen, P.O. Box 7804, NO-5020, Bergen, Norway., Lothe RA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway. rlothe@rr-research.no.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway. rlothe@rr-research.no.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, P.O. Box 4950, Nydalen, NO-0424, Oslo, Norway. rlothe@rr-research.no.

المصدر: Oncogene [Oncogene] 2019 Aug; Vol. 38 (33), pp. 6109-6122. Date of Electronic Publication: 2019 Jul 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

مواضيع طبية MeSH: Transcriptome*, Colorectal Neoplasms/*classification , Colorectal Neoplasms/*genetics , DNA Copy Number Variations/*physiology , Gene Amplification/*physiology, Colorectal Neoplasms/diagnosis ; Colorectal Neoplasms/mortality ; DNA Mutational Analysis ; Female ; Gene Dosage/physiology ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Microsatellite Instability ; Microsatellite Repeats ; Molecular Diagnostic Techniques/methods ; Survival Analysis ; Tumor Microenvironment/genetics

المؤلفون: Smeby J; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Sveen A; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Bergsland CH; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Eilertsen IA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Danielsen SA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Eide PW; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Hektoen M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Guren MG; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Nesbakken A; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway., Bruun J; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Lothe RA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

المصدر: ESMO open [ESMO Open] 2019 Jun 24; Vol. 4 (3), pp. e000523. Date of Electronic Publication: 2019 Jun 24 (Print Publication: 2019).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: eCollection Cited Medium: Print ISSN: 2059-7029 (Print) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: PubMed not MEDLINE

المؤلفون: Smeby J; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Sveen A; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Eilertsen IA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Danielsen SA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Hoff AM; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Eide PW; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Johannessen B; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Hektoen M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Skotheim RI; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Guren MG; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Nesbakken A; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway., Lothe RA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. ragnhild.a.lothe@rr-research.no.; K.G. Jebsen Colorectal Cancer Research Centre, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway. ragnhild.a.lothe@rr-research.no.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. ragnhild.a.lothe@rr-research.no.

المصدر: Oncogenesis [Oncogenesis] 2019 May 15; Vol. 8 (6), pp. 35. Date of Electronic Publication: 2019 May 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101580004 Publication Model: Electronic Cited Medium: Print ISSN: 2157-9024 (Print) Linking ISSN: 21579024 NLM ISO Abbreviation: Oncogenesis Subsets: PubMed not MEDLINE

المؤلفون: Høland M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Kolberg M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Danielsen SA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Bjerkehagen B; Department of Oral Biology, University of Oslo, Oslo, Norway.; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Eilertsen IA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Hektoen M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Mandahl N; Department of Clinical Genetics, University and Regional Laboratories, Lund University, Lund, Sweden., van den Berg E; Department of Genetics, The University Medical Center Groningen, Groningen, The Netherlands., Smeland S; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Mertens F; Department of Clinical Genetics, University and Regional Laboratories, Lund University, Lund, Sweden., Sundby Hall K; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Picci P; Laboratory of Experimental Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy., Sveen A; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Lothe RA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. rlothe@rr-research.no.; Institute for Clinical Medicine, University of Oslo, Oslo, Norway. rlothe@rr-research.no.

المصدر: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2018 Nov; Vol. 31 (11), pp. 1694-1707. Date of Electronic Publication: 2018 Jun 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol

مواضيع طبية MeSH: Nerve Sheath Neoplasms/*genetics , Nerve Sheath Neoplasms/*pathology , Neurofibrosarcoma/*genetics , Neurofibrosarcoma/*pathology , Tumor Suppressor Protein p53/*genetics, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Child ; Female ; Gene Amplification ; Genes, p53/genetics ; Humans ; Male ; Middle Aged ; Mutation ; Nerve Sheath Neoplasms/mortality ; Neurofibrosarcoma/mortality ; Prognosis ; Proto-Oncogene Proteins c-mdm2/genetics ; Young Adult

المؤلفون: Smeby J; Department of Molecular Oncology, Institute for Cancer Research; Division of Cancer Medicine, K.G. Jebsen Colorectal Cancer Research Centre; Department of Oncology, Oslo University Hospital, Oslo; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo., Sveen A; Department of Molecular Oncology, Institute for Cancer Research; Division of Cancer Medicine, K.G. Jebsen Colorectal Cancer Research Centre., Merok MA; Department of Molecular Oncology, Institute for Cancer Research; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway., Danielsen SA; Department of Molecular Oncology, Institute for Cancer Research; Division of Cancer Medicine, K.G. Jebsen Colorectal Cancer Research Centre., Eilertsen IA; Department of Molecular Oncology, Institute for Cancer Research; Division of Cancer Medicine, K.G. Jebsen Colorectal Cancer Research Centre., Guren MG; Division of Cancer Medicine, K.G. Jebsen Colorectal Cancer Research Centre; Department of Oncology, Oslo University Hospital, Oslo., Dienstmann R; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona; Vall d'Hebron University Hospital, Barcelona; Universitat Autonoma de Barcelona, Barcelona, Spain; Computational Oncology, Sage Bionetworks, Seattle, USA., Nesbakken A; Division of Cancer Medicine, K.G. Jebsen Colorectal Cancer Research Centre; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway., Lothe RA; Department of Molecular Oncology, Institute for Cancer Research; Division of Cancer Medicine, K.G. Jebsen Colorectal Cancer Research Centre; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo. Electronic address: ragnhild.a.lothe@rr-research.no.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 May 01; Vol. 29 (5), pp. 1227-1234.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*genetics , Colorectal Neoplasms/*mortality , Proto-Oncogene Proteins B-raf/*genetics , Proto-Oncogene Proteins p21(ras)/*genetics, Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/surgery ; DNA Mutational Analysis ; Datasets as Topic ; Disease-Free Survival ; Female ; Gene Expression Profiling ; Humans ; Male ; Microsatellite Instability ; Middle Aged ; Mutation ; Norway/epidemiology ; Predictive Value of Tests ; Prognosis ; Survival Analysis ; Transcriptome/genetics ; Young Adult